British Columbia Cancer Agency

This study looks at a type of radiation therapy for early-stage breast cancer where tiny radioactive seeds are placed directly into the breast after a lumpectomy. The goal is to improve the technique and see how well patients tolerate it, as well as compare costs with other radia…

This study looks at whether a special type of radiation called SABR can help people who have 1 to 3 spots where their cancer has spread. About 330 adults with controlled primary tumors will either get standard care alone or standard care plus SABR. The goal is to see if SABR impr…

This study compares two types of internal radiation boost (HDR vs LDR) given after external beam radiation for intermediate- or high-risk prostate cancer. The goal is to see which approach better controls the cancer while causing fewer side effects and improving quality of life. …

This study looks at whether a high-dose, targeted radiation treatment called SABR can safely control cancer that has spread to a few spots in the body (oligometastases). About 400 adults with up to 5 metastatic tumors will receive SABR, and researchers will track side effects, qu…

This study tests a new treatment called 177Lu-HTK03170 for men with a type of advanced prostate cancer that has stopped responding to hormone therapy. The treatment delivers radiation directly to cancer cells using a targeting molecule. The goal is to find a safe dose and see if …

This study is testing a new type of PET/CT scan that uses a special tracer (68Ga-DOTATOC) to find neuroendocrine tumors and other related cancers. The goal is to see if this scan is safer and more sensitive than current imaging methods. About 800 people with known or suspected tu…

This study compares two types of internal radiation therapy (brachytherapy) for men with early-stage prostate cancer. One uses low-dose radiation seeds placed permanently, the other uses high-dose radiation given in short sessions. The goal is to see which approach leads to bette…

This study looks at whether a blood test (liquid biopsy) can find cancer mutations as well as the standard tissue biopsy in 1,500 advanced cancer patients. The goal is to see if the blood test helps doctors choose better treatments and saves healthcare money. Participants either …